Revised. Amendments from Version 1
==================================

Minor changes incorporating reviewers' recommendations: \[1\] The legend in Figure 1 now defines the acronyms in the figure.\[2\] A new reference to Perezgonzalez (2015) now implies that the pseudoscientific label attached to the NHST element (Figure 1) follows from the rhetoric in such reference.\[3\] A second note clarifies that JASP also allows to use Cauchy, Normal and t-distributions as informed priors for the alternative hypothesis.\[4\] There is a new acknowledgement section.\[5\] A worked-out example on the parallel use of Fisher's and Jeffreys's tests has been appended (Supplementary File 1).

Argument
========

Seeking to address the lack of research reproducibility due to the high rate of false positives in the literature, [@ref-4]; [@ref-5] propose a pragmatic solution which "aligns with the training undertaken by many researchers, and might quickly achieve broad acceptance" (also [@ref-44]): to use a stricter *p* \< 0.005 standard for statistical significance when claiming evidence of new discoveries.

The proposal is subject to several constrains in its application: (1) to claims of discovery of new effects (thus, not necessarily to replication studies); (2) when using null hypothesis significance testing (arguably Fisher's approach, perhaps even Neyman-Pearson's, but excluding other *p*-value-generating approaches such as resampling); (3) in fields with too flexible standards (namely 5% or above); (4) when the prior odds of alternative-to-null hypothesis is in the range 1-to-5, to 1-to-40 (stricter standards are required with lower odds); (5) for researcher's consumption (thus, not a standard for journal rejection, although "journals can help transition to the new statistical significance threshold"; also, "journals editors and funding institutions could easily enforce the proposal", [@ref-48]; and "its implementation only requires journal editors to agree on the new threshold", [@ref-29]); (6) while still keeping findings with probability up to 5% as suggestive (and meriting publication if so "properly labelled"); (7) despite many of the proponents believing that the proposal is nonsense, anyway (that is, it is a quick fix, not a credible one; also Ioannidis in [@ref-13]; [@ref-42]; [@ref-48]; [@ref-49]).

The main analyses supporting the proposal were the following: (a) a calibration of *p*-values to Bayes factors under certain plausible alternatives (their Figure 1, [@ref-5], p. 2); (b) an estimated false positive rate under certain plausible prior odds of alternative-to-null hypotheses as a function of power (their Figure 2, [@ref-5], p. 3); and (c) a "critical mass of researchers now endors\[ing\] this change" (a.k.a., the 72 co-authors). Meanwhile, the proposal downplays the costs due to increasing sample size in order to ensure enough research power, the potential increase in false negatives and misconduct, and the existence of alternative solutions well known by, at least, some of the authors (despite [@ref-29], claim to the contrary).

Notwithstanding its potential impact, [@ref-4]; [@ref-5] proposal is not recognizant of the entire engine of science ( [Figure 1](#f1){ref-type="fig"}), which has motivated an even larger mass of authors to offer their counter-arguments.

![The engine of science (conceptual illustration).\
Xplore = exploratory data analysis; *ES* = effect size; *CI* = confidence interval, credible interval; *CCMA* = continuous cumulating meta-analysis; *MA* = meta-analysis; *Freq. replication* = frequentist replication; *NHST* = null hypothesis significance testing (as in [@ref-52]).](f1000research-6-14775-g0000){#f1}

Counter-arguments
=================

From **Philosophy of science**, [@ref-31], in particular, provides important counter-arguments against the philosophical standing of Benjamin *et al.*'s proposal. Quoting [@ref-20], Mayo asserts that whether *p*-values exaggerate the evidence against the null hypothesis depends on the philosophical background within which such claim is made: It may seem so from a Bayesian perspective, but both from a frequentist and an error statistics perspective, it is the Bayes factor which exaggerates the evidence (also 2017e). "I find it especially troubling"---she continues---"to spoze an error statistician...ought to use a Bayes Factor as the future gold standard for measuring his error statistical tool...even though Bayes Factors don't control or measure error probabilities" (2017b). Furthermore, Mayo pinpoints the (old) fallacy of transposing the conditional, whereby the (error) probability of a test is confused with the (posterior) probability of a belief (also [@ref-46]). And despite "60 years (sic) old...demonstrations \[showing\] that with reasonable tests and reasonable prior probabilities, the disparity vanishes...they still mean different things" (2017c). In particular, "in an adequate account \[of severity testing\], the improbability of a claim must be distinguished from its having been poorly tested. (You need to be able to say things like, 'it's plausible, but that's a lousy test of it.')" (2017d). And "the method for such checking is significance tests!" (2017b).

From **Methodology**, a large number of critics have faulted Benjamin *et al.*'s disregard of what is really affecting replication in order to focus on a relatively minor issue. Mayo, for example, lists biasing selection effects, cherry-picking, multiple testing, hunting for significance, optional stopping, violated statistical assumptions, missing or irrelevant statistical-substantive links, and questionable measurements as the main culprits in flawed findings and lack of reproducibility (2017a--e; also [@ref-18]; [@ref-17]). [@ref-26] add lack of experimental redundancy, logical traps, research opacity, and poor accounting of sources of error, as well as the risks of reduced generalisability and research breadth were Benjamin *et al.*'s proposal to succeed. Methodological concerns were also raised by [@ref-1]; [@ref-6]; [@ref-7]; [@ref-8]; [@ref-10]; [@ref-14]; [@ref-19]; [@ref-21]; [@ref-23]; [@ref-27]; [@ref-28]; [@ref-30]; [@ref-37]; [@ref-40]; [@ref-45]; [@ref-46]; [@ref-50]; [@ref-51]; and [@ref-36]. Some researchers even propose the use of preregistration as a way of minimizing above problems ( [@ref-21]; [@ref-28]; [@ref-47])

The pseudoscientific **NHST element** (as conceptualized in [@ref-52]) is the cornerstone of Benjamin *et al.*'s proposal, as it mixes Fisher's tests of significance with Neyman-Pearson's alternative hypotheses, Type II errors and power estimation, and with Bayesian prior probabilities, in order to argue about the false positive rate as the culprit for the lack of replicability. Indeed, the false positive rate argument has been heavily criticized by several authors: [@ref-32]; also [@ref-7]) chiefly derides as questionable the prior probabilities given to the hypotheses; [@ref-9] denounces the credibility of Benjamin *et al.*'s false positive rate calculation for some of the prior probabilities used, which he sees as a rather liberal rate; [@ref-8]; also [@ref-7]) claims that the prior probability ratios for the hypotheses are not realistic; [@ref-28] raises an argument on prior probabilities and their combination with accumulated evidence in order to estimate the probability of future replication, not finding a more restrictive level of significance an adequate antecedent for increasing such probability; [@ref-24] adds that, under the new proposal, the proportion of false negatives rises faster than the speed at which false positives drops, leading [@ref-39] to wonder whether, because of it, "it makes more sense to increase, rather than reduce, the significance level for novel findings"; [@ref-23] states that the false positive rate formula is misleading and finds the expected false positive rate when testing the conventional 5% threshold.

Furthermore, [@ref-41] argued that the misinterpretation of *p*-values as evidence in favour or against a hypothesis has more to do with the pseudoscientific use of NHST than with frequentist testing proper (also [@ref-1]; [@ref-32]; [@ref-37]). As Benjamin *et al.*'s proposal is made within the pseudo-philosophical argument of NHST (e.g., confusing statistical and substantive significance; [@ref-33]), a lower threshold of significance does not improve such 'magical thinking' (also [@ref-2]; [@ref-12]; [@ref-19]; [@ref-24]; [@ref-39]). [@ref-26]; also [@ref-36]; [@ref-38]) equally warn that the proposal exaggerates the focus on single *p*-values in scientific practice, education, decision making and publication.

**Unsupported conclusions** are another consequence of pseudoscientific thinking, and [@ref-37] and [@ref-1] highlight the risks of studies published under the new banner exaggerating effect sizes and overconfidence in significant results while discounting non-significant findings. [@ref-11] argues, instead, for the need to be humbler and not generalize to populations, irrespective of statistical significance, effects that may only be present in the sample.

The **descriptive data analysis** element was briefly touched upon by [@ref-31]---who recommends abandoning significance testing in favour of inferring the magnitudes that are well (or poorly) indicated by the data (a.k.a., CIs)---and [@ref-27], [@ref-39], and [@ref-37]---whom argue for the need to interpret evidence in the context of other findings and theoretical models in lieu of NHST.

Regarding **data testing**, [@ref-31]; [@ref-32] and [@ref-41] have no particular problem with a lower level of significance although both reckon Benjamin *et al.*'s proposal does not address anything in particular with frequentist testing proper. Mayo equally sees such lowering unnecessary as "you might not want to be too demanding before claiming evidence of a \[null\] model violation" (2017b), while the "lack of replication is effectively uncovered thanks to statistical significance tests" (2017e). [@ref-50] reminds us of the appropriate use of significance tests in experimental contexts. [@ref-37] also argues the credibility of uniformly most powerful priors and tests and the loss of its connection to Bayesianism as for justifying Benjamin *et al.*'s proposal (but see [@ref-49]).

Other authors recommend continuing using *p*-values either as part of frequentist tests proper ( [@ref-3]) or without significance testing, the latter including [@ref-9], [@ref-32]; who also proposes estimating false positive rates), [@ref-19], who proposes transforming them to bits of information against the null hypothesis), [@ref-12]; [@ref-15]; [@ref-26], who recommend justifying whatever thresholds may be used at the design stage), [@ref-37], who recommend using them as descriptives among other neglected factors---but see [@ref-49], counter-argument, and [@ref-16], counter-counter-argument), and [@ref-1]. [@ref-2] suggests substituting Bayesian statistics, instead.

Addressing **replication** directly, [@ref-8] and [@ref-46] point out that the problem with replication is not too many false positives but insufficient power. [@ref-24]; also [@ref-37], [@ref-46]) chides Benjamin *et al.* for the incoherence of considering replication as order-dependent and inverting the exploratory-confirmatory nature of replication by proposing to make the former more difficult to achieve and the latter more liberal. He further chides them on whether they would disallow their own past findings at the 5% threshold. [@ref-26]; also [@ref-10]) found biases in the analyses done by Benjamin *et al.*, and conclude that there is no \[Bayesian\] evidence that a lower level of significance improves replicability. They also warn of the risks of fewer availability of replication studies were the proposal to succeed (also [@ref-19]). [@ref-17]; [@ref-21]; [@ref-22]; [@ref-23]; [@ref-43], and [@ref-46] propose to stop the proverbial beating around the bushes and perform direct replications as a straightforward measure of replicability.

The **hypothesis testing** element (namely full Bayesian hypothesis testing) has been seldom touched upon but briefly by [@ref-28], who extended the need for prior probabilities and even more accumulated evidence as pre-requisite for estimating the probability of hypotheses being 'true'.

In conclusion, despite Benjamin *et al.*'s best intentions, their proposal only reinforces the NHST pseudoscientific approach with a stricter bright-line threshold for claiming evidence it cannot possibly claim---irrespective of how well it calibrates with Bayes factors under certain conditions---while dismissing potential consequences such as the stifling of research and its publication, an increase in false negatives, an increase in misbehaviour, and a continuation of pseudoscientific practices. Furthermore, theirs is a frequentist solution many of their Bayesian proponents do not even believe in, born out of a false belief of lacking equally simple but better-suited alternatives ( [@ref-29]).

In reality, an equally simple and better suited alternative exists, perhaps the only one the authors could be entitled to make from their Jeffresian perspective, hence our own recommendation: Use JASP, the stand-alone, free-to-download, R-based statistical software with user-friendly interface, developed by Wagenmakers' team ( <https://jasp-stats.org> ^[1](#fn1){ref-type="other"}^). JASP allows for analysing the same dataset using frequentist (Fisher's tests of significance) and Bayesian tools (Jeffreys's Bayes factors ^[2](#fn2){ref-type="other"}^) without necessarily forcing a mishmash of philosophies of science (e.g., see [Supplementary File 1](#SF1){ref-type="other"}). JASP allows for the Popperian (also Meehl's, Mayo's) approach to severely testing a null hypothesis but also to ascertain the credibility of tests based on the observed data. JASP allows researchers to qualitatively calibrate their significance tests to Bayes factors but also the possibility of calibrating Bayes factors to frequentist tests so as to ascertain their error probabilities. JASP is an existing simple and easy application that shows two interpretations of the same data, which aligns well with the training undertaken by frequentist and Jeffreysian researchers alike while allowing them the opportunity to learn the alternative philosophy---irrespective of which they will choose for publication---and may as well help diminish the misinterpretation of results and the reaching of unsupported conclusions. In so doing, it may even help improve replicability.

Notes
=====

^1^Worthy alternatives are Morey's R package for Bayes factors ( <http://bayesfactorpcl.r-forge.r-project.org>), Morey's Bayes factor calculator ( <http://pcl.missouri.edu/bayesfactor>), and Dienes's Bayes factor calculator ( <http://www.lifesci.sussex.ac.uk/home/Zoltan_Dienes/inference/Bayes.htm>). Even better would be to skip comparing models altogether and go for full Bayesian hypothesis testing (e.g., [@ref-25]). Yet none of those alternatives surpass, at present, JASP's interface and its flexibility for parallel analysis.

^2^The latest versions of JASP (e.g. 0.8.4.0; 0.8.5.1) also allows for choosing informed priors based on Cauchy, Normal, and *t*-distributions.

We wish to thank the reviewers, P. Tressoldi, J. C. Ramos, and S. Senn for their reviews and suggestions for improvement.

Supplementary material
======================

Supplementary file 1: **Parallel statistical analysis via JASP**. Example of data analysis using both frequentist (Fisher) and Bayesian (Jeffreys) approaches.

Click here for additional data file.
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I consider this is a valid contribution to the debate on this topic but like many such contributions it reflects a particular viewpoint, my own contributions ^[@rep-ref-28963-1]^ in this field are no exception, and like many contributors, and, again, I am probably also guilty, there is minimal recognition that their own views are not reasonable from other perspectives. In particular (see below) they are over-fond of the adjective *pseudoscientific*and their use of it without further justification is, in my view, a form of pseudo-argumentation.

Particular objections that I have are the following. They state: \"The pseudoscientific **NHST element** is the cornerstone of Benjamin *et al.*'s proposal, as it mixes Fisher's tests of significance with Neyman-Pearson's alternative hypotheses.\" This, in my opinion, is an unsubstantiated and misleading jibe. First, although this claim is often made, it is not correct that NHST is some sort of monstrous hybrid of Neyman-Pearson (N-P) and Fisherian views. It very naturally uses common elements that belong in both.(2) For instance, Fisher, although usually associated with P-values, introduced the habit of tabulating percentage points in *Statistical Methods for Research Workers*. Secondly, as Lehmann, a classic proponent of the N-P view explained in *Testing Statistical Hypotheses*, P-values are a practical way of allowing scientist who may not agree on  appropriate Type I error rates to share results efficiently. Furthermore, although I have little enthusiasm for  what Benjamin et al are doing, I think that fact that NHST seems to represent some sort of a fusion of Fisher and NP (a point that is much exaggerated and of little relevance)  is the least important aspect of what they are doing. If they had rejected everything the Fisher proposed and described what they were doing as trying to convince diehard N-P acolytes that the common 5% level was better changed to 0.5%, it would have zero technical effect on what they are proposing and would not make it either better or worse. Whatever problems or virtues there are with the Benjamin et al proposal, the Fisher, N-P fusion is a complete red herring.Will JASP and Bayes Factors (BF) really save statistical inference? I doubt it. One of the problems with the Jeffreys approach is the huge influence that the lump of probability on the \'null\' has on the posterior inference. NHST is far less dependent on this and, in a context in which I work, that of drug development, the practical challenge is to avoid recommending a treatment that is worse. it is a strength of NHST that one does not have to worry too much about whether one is talking about [precise(or point hypotheses) on the one hand or dividing ones on the other](https://errorstatistics.com/2015/03/16/stephen-senn-the-pathetic-p-value-guest-post/). Of course, Bayesians could regard this as not a strength but a weakness, on the lines that if it *does* make a difference to Bayesian posterior statements ( [and the difference can be enormous](https://errorstatistics.com/2015/05/09/stephen-senn-double-jeopardy-judge-jeffreys-upholds-the-law-guest-post/)) it *ought* to in the NHST context. (It is a very common habit of Bayesians to abrogate the right of judging other systems by theirs.) However, I also note that amongst the Bayesian commentators on the recent ASA statement, some dismissed precise hypotheses as being completely irrelevant.Like many commentators, they appear to accept much of the replication crisis at face value. However, there are four aspects here that are important. i) Gaming can effect any system (as they recognise)  ii) Much of the discussion has taken it as obvious that  failure to replicate is a problem of the original study *only*, rather than a shared problem. However, it can only be the former if the second study is perfect and that includes not being subject to sampling variation itself. What thus becomes important is to judge how well studies of infinite size are predicted, not those that just happen to be the same size as the original (2). iii) It assumes that what is important is the extent to which the P-value predicts the P-value but there is no claim under NHST that this is so. What is relevant is the extent to which it predicts the sign of the true difference Furthermore, to shackle the Bayesian approach with the same standard (what\'s sauce for the goose is sauce for the gander) would require that a high BF predicted a further high BF ( *using data from the subsequent study only*) with high probability. JASP on its own will not deliver this. iv) Finally, if the only replication that matters is failure to replicate \'significance\' then the proposal of Benjamin et al is nowhere near radical enough. \'Significance\' must never be granted. On the other hand, if false negatives are also a problem, and not just false positives, then the solution has to be rethought from the beginning. (To be fair to the authors, they do cite Krueger\'s, 2017 warning about this but it is unclear to me to what extent they take it on board in what they are proposing.) However, putting aside my objections to some of the polemics of the article, the idea of supplementing P-values by other inferential statistics strikes my as being sensible and I certainly approve their suggestion of keeping Bayes factors separate from P-values. In fact, I have no objection to Bayes Factors provided that their very tentative nature is recognised and I certainly sign up to the idea of the utility of having different ways of looking at data ^[@rep-ref-28963-3]^ ^[@rep-ref-28963-4]^.

I have read this submission. I believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.
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The authors discuss the article by Benjamin et al., 2017 and their proposal of p \<.005 as a possible solution to the lack of research reproducibility due to the high rate of false positives in the literature. The article reviews the current debate topics on NHST and contributes to the reflection on how to advance towards a Science that allows accumulating valid scientific knowledge. Suggestions: Write down at the end of the article a simple example where the result is interpreted with NHST and with the Bayes factor and the utility of JASP is presented.
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Thank you very much for your prompt review. I will append an example to address your suggestion as soon as a current research using a double frequentist/Jeffresian approach is concluded.
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This is a timely and well organized synthesis of the debate ignited by Benjamin *et al*. ['s]{.ul}, 2017 influential paper which is still going on.

My only suggestions are the followings:

\- to add a legend to the acronyms in Figure 1, e.g. ES, CI, etc.;

\- to correct the statement that the JASP software allows only a Jeffreys's Bayes Factor given that in the present .8.4.0 version, the user can also choose informed priors based on Cauchy, Normal or t distributions;

\- I think that a final synoptic table related to the information offered by the different statistical indices, i.e., *p* value, CI, Bayes Factor ~H1/H0~, Effect Size, etc., could help the readers acknowledge the different informational value among them and consequently to choose those ones which answer better the questions they ask their data.
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Thank you very much for your prompt review. I will upload a new version incorporating two of the suggestions made (plus proper acknowledgement). I will append an example to address the third suggestion as soon as a current research using a double frequentist/Jeffresian is finished.

[^1]: No competing interests were disclosed.
